Navigation Links
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
Date:8/7/2009

ST. LOUIS, Aug. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") today announced that the Company notified certain owners of the Company's Class A and Class B Common Stock, as further described below (the "Reporting Persons"), that the stockholder action by written consent purported to have been taken by such Reporting Persons on August 5, 2009 does not comply with the requirements of the Company's By-Laws and is therefore invalid and not effective.

Specifically, on August 5, 2009, the Reporting Persons filed with the U.S. Securities and Exchange Commission (the "SEC") a Schedule 13D disclosing their beneficial ownership of the Company's Class A Common Stock and a Schedule 13D disclosing their beneficial ownership of the Company's Class B Common Stock. Such Reporting Persons included Marc S. Hermelin, the Company's former chief executive officer and a current member of the Company's Board of Directors (the "Board"), David S. Hermelin, a member of the Board and the son of Mr. Marc S. Hermelin, and certain other persons, including various family members and trusts associated with Mr. Marc S. Hermelin.

The Schedules 13D filed by the Reporting Persons, which are available on the SEC's EDGAR website at www.sec.gov, also disclosed that such Reporting Persons have executed and delivered to the Company a purported action by written consent of stockholders relating to the adoption of certain amendments to the Company's By-Laws. A copy of such stockholder written consent was filed as an exhibit to each Schedule 13D. The Company received an executed copy of such stockholder written consent on August 5, 2009.

On August 7, 2009, the Company notified the Reporting Persons by letter that, because the Reporting Persons have failed to comply with Article II, Section 12 of the Company's By-Laws (requiring a stockholder seeking to act by written consent
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
2. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
3. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
4. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
5. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
8. ADVENTRX Pharmaceuticals Announces Financing
9. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
10. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Scientists, researchers, and technologists will converge ... Damage 2014 symposium. Marking its 46th year, the ... run 14-17 September. The event is sponsored by ... , The premier conference for basic and applied issues ... materials will engage researchers and engineers from numerous industries ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 ... wholesale construction materials, selected SoundConnect to ... their cloud based audio and web conferencing platform ... to support PrimeSource’s employees’ needs. SoundConnect delivers ... , PrimeSource Building Products will be utilizing ...
(Date:8/27/2014)... August 27, 2014 Varian Medical Systems ... its current Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full time jobs ... , “Utah is home to hardworking people with immense ... credited with Varian’s success in the manufacturing of our ...
(Date:8/27/2014)... August 27, 2014 In 2013, ... Lawrence Livermore National Security LLC (LLNS), ... and deliver a state-of-the-art laser system for the ... Beamlines), under construction in the Czech Republic. , ... laser system, called the " High repetition-rate Advanced ...
Breaking Biology Technology:Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3
...  A recent Van Andel Research Institute (VARI) study published in ... function of an essential plant hormone could profoundly change our ... to the development of new drugs for a variety of ... by the same team of investigators at VARI that was ...
... 2012  PinneyAssociates, Inc., a health care consulting firm with offices ... the following promotions, effective 1 January 2012: , ... , Lucy Owen, to Vice President, Program Operations and ... President , Joe Gitchell, to President , John ...
... Aethlon Medical, Inc. (OTCBB: AEMD), the ... address infectious disease, cancer and other life-threatening conditions, ... Therapy Scientific Advisory Board to guide the advancement ... from the Aethlon ADAPT™ system.  Aethlon recently established ...
Cached Biology Technology:Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process 2PinneyAssociates Announces Senior Staff Promotions 2Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 2Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 3Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 4Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 5Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 6Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board 7
(Date:8/29/2014)... 29, 2014) Scientists at the Barshop Institute for ... Medicine at the UT Health Science Center at San ... tissues of the longest-lived rodent, the naked mole rat. ... cells of naked mole rats protects and alters the ... and obsolete proteins. , The factor also protects proteasome ...
(Date:8/29/2014)... release is available in German . ... players in the natural nitrogen cycle on Earth and ... bacteria were thought to depend on nitrite as their ... by Holger Daims, a microbiologist at the University of ... hydrogen as an alternative source of energy. The oxidation ...
(Date:8/29/2014)... Boulder, Colo., USA - The rise of the Tibetan ... on Earth -- is important for both its profound ... In this study published in GSA Bulletin , ... -- "clumped" isotope thermometry -- using modern and fossil ... Zhada basin in southwestern Tibet. , Views range ...
Breaking Biology News(10 mins):Factor in naked mole rat's cells enhances protein integrity 2Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
... (UH) executed two license agreements with SuperPower, a ... covers the intellectual property on second generation (2G) ... under the Sponsored Research Agreement (SRA) previously executed ... is led by Venkat Selvamanickam, M.D. Anderson chair ...
... the Ministry of Public Health and Sanitation, together with ... Adolescent Health), unveiled a renewed set of national policy ... by putting proven interventions to work within the country,s ... global progress against diarrhoea has stalled. Contrary to what ...
... with legends of European monarchs, frail heirs and one flamboyant ... the very treatments that can help can also put patients, ... an expensively produced protein that helps the blood to clot. ... and in a subset of those, it sets off an ...
Cached Biology News:SuperPower and UH sign high temperature superconducting wire license agreements 2Policy unveiled to combat diarrheal disease, a killer of Kenyan children 2Policy unveiled to combat diarrheal disease, a killer of Kenyan children 3Researchers harness the power of plants to fight hemophilia 2Researchers harness the power of plants to fight hemophilia 3Researchers harness the power of plants to fight hemophilia 4
Request Info...
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (Z71,405-4) or contact customer ... 60 mm volume diam. 3 ...
Contact us for more information...
... to rapidly and reliably amplify unknown genomic ... APAgene provides hassle-free, ready-to use components, at ... are provided in each kit. The Genome ... filling, localized cloning of genomic DNA, isolating ...
Biology Products: